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Effects of Zinc Supplementation onAntioxidant Status
and Lipid Peroxidation in Hemodialysis Patients
Mohammad Mazani, PhD,* Hassan Argani, MD,† Nadereh Rashtchizadeh, PhD,‡
Amir Ghorbanihaghjo, PhD,‡ Amir Hamdi, MD,§ Mehrdad Asghari Estiar,{
and Nariman Nezami, MD**
Objectives: This study was designed to determine the effects of zinc supplementation on oxidative stress in hemodialysis (HD)
patients through evaluating total antioxidant capacity (TAC), whole blood glutathione peroxidase (GSH) level, superoxide dismutase
(SOD) activity, and malondialdehyde (MDA) level.
Design and Setting: Double-blinded randomized controlled trialfrom October 2006 to December 2007 at Tabriz Imam Khomeini
Hospital.
Subjects: Sixty-five HD patients were randomly enrolled into 2 groups.
Intervention:Patients received placebo in groupA and zinc (100mg/day) in groupB for 2months. After awashout period for 2months,
the groups were crossed over and the study was continued for an additional 2 months.
Main outcome measures: Serum zinc concentration was measured using atomic absorption spectrophotometry. TAC, GSH level,
and SOD activity were determined by commercial enzyme-linked immunosorbent assay kits. MDA level was measured using a thiobar-
bituric acid method.
Results: The levels of serum zinc, TAC, GSH (P, .001 for all), and SOD activity (P, .001 for group A and P5 .003 for group B) sig-
nificantly increased after zinc supplementation whereas the serum level of MDA decreased after the same period (P5 .003 for group A
and P , .001 for group B).
Conclusions: Zinc supplementation for 2 months improved the serum levels of zinc, antioxidant status, and lipid peroxidation in HD
patients.
! 2013 by the National Kidney Foundation, Inc. All rights reserved.
Introduction
ZINC IS AN essential trace element that is required forthe function of more than 300 enzymes and many
other biological factors, including hormones, cytokines,
peptides, and biomembranes.1 In addition, zinc plays a crit-
ical role in gene expression, protein synthesis, bone forma-
tion, growth, reproduction, wound healing, transport
processes, immune function, and behavioral responses.1
Zinc deficiency is a worldwide problem, and it is esti-
mated that 25% of the world’s population is at risk of zinc
deficiency.2 Lower levels of zinc were specifically reported
in hemodialysis (HD) patients.3,4 Deficiency of zinc has
been associated with most of the uremic symptoms,
including anorexia, hypogeusia, hyposmia, and disorders
of sexual and immunological functions.1,3 Studies have
shown that zinc supplementation increases the serum level
of zinc in HD patients5 and improves uremic symptoms.6,7
Furthermore, the antioxidant properties of zinc have
been clearly demonstrated and, for the most part, appear
to be independent of zinc metalloenzyme activity.8-12
The antioxidative action of zinc can be generally divided
into acute and chronic effects. The acute effect involves
two mechanisms: protection of protein sulfhydryls or
reduction of hydroxyl formation from hydrogen peroxide
through the antagonism of redox-active and transition
metals including iron and copper.13 The chronic effect in-
volves exposure of an organism to zinc on a long-term basis,
resulting in induction of some other substances that are the
ultimate antioxidant such as metallothioneins.13 Therefore,
zinc deficiency in uremic and HD patients may result in in-
creased oxidative stress, which is implicated in several path-
ologic processes such as cardiovascular disorders.9-12,14,15
On the basis of the antioxidative properties of zinc and its
deficiency in HD patients, the study presented here aimed
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